These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23839126)

  • 1. Investors start backing hearing loss treatments.
    Sheridan C
    Nat Biotechnol; 2013 Jul; 31(7):575-6. PubMed ID: 23839126
    [No Abstract]   [Full Text] [Related]  

  • 2. Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry.
    Bertram TA; Tentoff E; Johnson PC; Tawil B; Van Dyke M; Hellman KB
    Tissue Eng Part A; 2012 Nov; 18(21-22):2187-94. PubMed ID: 22838399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hearing loss and tinnitus: 250 million people and a US$10 billion potential market.
    Vio MM; Holme RH
    Drug Discov Today; 2005 Oct; 10(19):1263-5. PubMed ID: 16214667
    [No Abstract]   [Full Text] [Related]  

  • 4. Regenerative medicine through a crisis: social perception and the financial reality.
    Brindley D; Davie N
    Rejuvenation Res; 2009 Dec; 12(6):455-61. PubMed ID: 20041739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aligning needs.
    Ford D; Kohlbrenner W
    Nat Biotechnol; 2016 Mar; 34(3):226-30. PubMed ID: 26963540
    [No Abstract]   [Full Text] [Related]  

  • 6. Tissue engineering/regenerative medicine ventures should invest early in market research to understand the future market's needs.
    Gemmiti C
    Tissue Eng Part B Rev; 2013 Apr; 19(2):97-8. PubMed ID: 23327734
    [No Abstract]   [Full Text] [Related]  

  • 7. What investors are looking for. More private equity is coming into the market, but what do investors want?
    Miller J
    Behav Healthc; 2015; 35(2):46. PubMed ID: 26027090
    [No Abstract]   [Full Text] [Related]  

  • 8. Global Hearing Loss Prevention.
    Brown CS; Emmett SD; Robler SK; Tucci DL
    Otolaryngol Clin North Am; 2018 Jun; 51(3):575-592. PubMed ID: 29525388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hearing loss: economic impact.
    Sataloff RT
    Ear Nose Throat J; 2012 Jan; 91(1):10-2. PubMed ID: 22278860
    [No Abstract]   [Full Text] [Related]  

  • 10. Relative earnings of deaf and hard-of-hearing individuals.
    Jones DD
    J Deaf Stud Deaf Educ; 2004; 9(4):459-61. PubMed ID: 15314018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What investors look for in a genomics venture.
    Wolf R
    MLO Med Lab Obs; 2010 Aug; 42(8):32-3. PubMed ID: 20734898
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost effectiveness of strategies to combat vision and hearing loss in sub-Saharan Africa and South East Asia: mathematical modelling study.
    Baltussen R; Smith A
    BMJ; 2012 Mar; 344():e615. PubMed ID: 22389341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between hearing loss and healthcare expenditures in older adults.
    Foley DM; Frick KD; Lin FR
    J Am Geriatr Soc; 2014 Jun; 62(6):1188-9. PubMed ID: 24925555
    [No Abstract]   [Full Text] [Related]  

  • 14. Strategic investors: private equity fund expands and diversifies.
    Evans M
    Mod Healthc; 2012 Jun; 42(23):10-1. PubMed ID: 22741425
    [No Abstract]   [Full Text] [Related]  

  • 15. [Public assistance for the management of hearing loss].
    Quéruel F
    Rev Prat; 2009 May; 59(5):657-63. PubMed ID: 19552205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTOR Signaling in the Inner Ear as Potential Target to Treat Hearing Loss.
    Cortada M; Levano S; Bodmer D
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34198685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bumpy ride for stocks. But hospital investors see reform as positive.
    Galloro V
    Mod Healthc; 2010 Sep; 40(38):12-3. PubMed ID: 20931898
    [No Abstract]   [Full Text] [Related]  

  • 18. Medical developments get small investors' backing in Canada.
    Spurgeon D
    Nature; 1996 Aug; 382(6590):384. PubMed ID: 8684474
    [No Abstract]   [Full Text] [Related]  

  • 19. IPOs put on hold. Medical-tech companies struggle to find investors.
    Rhea S
    Mod Healthc; 2009 Jan; 39(1):16. PubMed ID: 19230088
    [No Abstract]   [Full Text] [Related]  

  • 20. Investors likely to venture back as crisis subsides.
    Glick JL
    Nature; 2009 Aug; 460(7259):1079. PubMed ID: 19713912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.